UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported): | January 31, 2018 |
MKS Instruments, Inc.
__________________________________________
(Exact name of registrant as specified in its charter)
Massachusetts | 000-23621 | 04-2277512 |
_____________________ (State or other jurisdiction |
_____________ (Commission |
______________ (I.R.S. Employer |
of incorporation) | File Number) | Identification No.) |
2 Tech Drive, Suite 201, Andover, Massachusetts | 01810 | |
_________________________________ (Address of principal executive offices) |
___________ (Zip Code) |
Registrants telephone number, including area code: | 978-645-5500 |
Not Applicable
______________________________________________
Former name or former address, if changed since last report
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company [ ]
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [ ]
Item 2.02 Results of Operations and Financial Condition.
On January 31, 2018, MKS Instruments, Inc. announced its financial results for the quarter and year ended December 31, 2017. The full text of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K.
The information in this Form 8-K and the Exhibit attached hereto shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 (the "Exchange Act") or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as expressly set forth by specific reference in such a filing.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
99.1 Press Release dated January 31, 2018
Exhibit Index
Exhibit No. | Description | |
|
|
|
99.1
|
Press Release dated January 31, 2018 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
MKS Instruments, Inc. | ||||
January 31, 2018 | By: |
/s/ Seth H. Bagshaw
|
||
|
||||
Name: Seth H. Bagshaw | ||||
Title: Senior Vice President, Chief Financial Officer and Treasurer |
(MKS LOGO)
EXHIBIT 99.1
MKS Instruments Reports Fourth Quarter and
Full Year 2017 Financial Results
2017 was a record year in revenue and GAAP and Non-GAAP EPS |
| Annual revenue increased 30% compared to pro-forma 2016 to a record $1.9 billion |
| Annual semiconductor revenue increased 45% on a pro-forma basis to a record $1.1 billion |
| Annual revenue in advanced markets increased 14% on a pro-forma basis to a record $820 million |
| Light and Motion set new quarterly and annual revenue records and in Q417 exceeded $200 million in revenue for the first time |
Our 2018 January Operating Model shows a 33% increase in Non-GAAP EPS compared to the October 2017 Operating Model
Andover, Mass., January 31, 2018 MKS Instruments, Inc. (NASDAQ: MKSI), a global provider of technologies that enable advanced processes and improve productivity, today reported fourth quarter and full year 2017 financial results.
GAAP Financial Results1
Q4 | Full Year | |||||||||||||||
2017 | 2016 | 2017 | 2016 | |||||||||||||
Net revenues ($ millions) |
$ | 512 | $ | 405 | $ | 1,916 | $ | 1,295 | ||||||||
Operating margin |
23.4 | % | 15.4 | % | 21.2 | % | 12.1 | % | ||||||||
Net income ($ millions) |
$ | 77.6 | $ | 45.5 | $ | 339.1 | $ | 104.8 | ||||||||
Diluted EPS |
$ | 1.41 | $ | 0.83 | $ | 6.16 | $ | 1.94 |
Non-GAAP Financial Results1
Q4 | Full Year | |||||||||||||||
2017 | 2016 | 2017 | 2016 | |||||||||||||
Net revenues ($ millions) |
$ | 512 | $ | 405 | $ | 1,916 | $ | 1,295 | ||||||||
Operating margin |
25.9 | % | 20.6 | % | 24.6 | % | 18.7 | % | ||||||||
Net earnings ($ millions) |
$ | 94.6 | $ | 57.2 | $ | 328.2 | $ | 164.0 | ||||||||
Diluted EPS |
$ | 1.71 | $ | 1.05 | $ | 5.96 | $ | 3.03 |
1 | The full year 2016 results include the results of Newport Corporation (now the Light and Motion segment) since its acquisition on April 29, 2016. |
Fourth Quarter Financial Results
Sales were $512 million, an increase of 5% from $486 million in the third quarter of 2017, and an increase of 26% from $405 million in the fourth quarter of 2016.
Fourth quarter net income was $77.6 million, or $1.41 per diluted share, compared to net income of $76.0 million, or $1.38 per diluted share in the third quarter of 2017, and $45.5 million, or $0.83 per diluted share in the fourth quarter of 2016.
Non-GAAP net earnings, which exclude special charges and credits, were $94.6 million, or $1.71 per diluted share, compared to $85.9 million, or $1.56 per diluted share in the third quarter of 2017, and $57.2 million, or $1.05 per diluted share in the fourth quarter of 2016.
Sales to semiconductor customers were $284 million, an increase of 1% compared to a strong third quarter of 2017, and sales to advanced markets were $228 million in the quarter, an increase of 11% sequentially driven largely by strong growth from our Light and Motion Division.
Sales in the Vacuum and Analysis segment, the historic MKS business, set a quarterly record of $311 million, driven by very strong sales to semiconductor customers. Sales in the Light and Motion segment, the historic Newport business, also set a quarterly record of $201 million.
Additional Financial Information
The Company had $543 million in cash and short-term investments as of December 31, 2017 and $398 million outstanding under its Term Loan. During the fourth quarter, the Company made another voluntary Term Loan repayment of $50 million and paid a dividend of $9.8 million or $0.18 per diluted share.
Full Year Results
Sales were a record $1.92 billion, an increase of 30% from $1.47 billion in 2016 on a pro-forma basis (assuming the acquisition of Newport Corporation had occurred as of the beginning of 2016), driven by strong sales to both semiconductor customers as well as customers in thin film manufacturing, industrial manufacturing, and health and life sciences. Sales to semiconductor customers were $1.1 billion, an increase of 45% compared to 2016, also on a pro-forma basis, while sales to advanced markets were $820 million, an increase of 14%.
Sales in the Vacuum and Analysis segment were $1.2 billion, an increase of 38% from $872 million in 2016, driven by very strong sales to semiconductor customers, which increased nearly 50% from 2016.
Sales in the Light and Motion segment were $709 million, an increase of 18% from $602 million in 2016, on a pro-forma basis driven by both sales to semiconductor customers as well as industrial manufacturing customers.
We are very pleased with our fourth quarter and full year 2017 results, which set new records for revenue and profitability, in both of our segments, said Gerald Colella, Chief Executive Officer and President. Mr. Colella added, This strong performance reflects our focused strategy of achieving sustainable and profitable growth by providing customers with innovative technology solutions, continuing to streamline all aspects of our operations, and investing in high-growth solutions and markets. Moreover, our ability to successfully grow and integrate Newport into the existing MKS business helped us deliver these strong results and positions us for future success.
The acquisition of Newport Corporation coupled with our organic growth has enabled us to nearly double non-GAAP EPS in 2017 compared to 2016, said Seth Bagshaw, Senior Vice President and Chief Financial Officer. Mr. Bagshaw added These achievements are reflected in our newly published January 2018 Operating Model, which demonstrates our continued and long standing efforts to drive improvements in our operating leverage. Furthermore, recently enacted U.S. Federal tax reform legislation is positive for MKS and is expected to result in a significant reduction in our effective tax rate while providing more long term flexibility in our use of cash.
First Quarter 2018 Outlook
Based on current business levels, the Company expects that sales in the first quarter of 2018 may range from $510 to $550 million, and at these volumes, GAAP net income could range from $1.68 to $1.95 per diluted share and non-GAAP net earnings could range from $1.86 to $2.12 per diluted share. This financial guidance incorporates assumptions made based upon the Companys current interpretation of the 2017 Tax Cut and Jobs Act, and may change as additional clarification and implementation guidance is issued.
January 2018 Operating Model
The Company also published an updated operating model, which reflects an illustrative revenue level of $2.2 billion, improvements in gross margin, lower interest expense, and the expected impact of the 2017 Tax Cut and Jobs Act. As a result of these improvements, non-GAAP EPS in the model increased by 33% to $8.55 compared to $6.42 in the prior operating model, published in October of 2017, and represents an improvement in non-GAAP EPS of more than 80% compared to the model entering 2017.
A conference call with management will be held on Thursday, February 1, 2018 at 8:30 a.m. (Eastern Time). To participate in the conference call, please dial (877) 212-6076 for domestic callers and (707) 287-9331 for international callers, and an operator will connect you. Participants will need to provide the operator with the Conference ID of 5595206, which has been reserved for this call. A live and archived webcast of the call will be available on the Companys website at www.mksinst.com.
About MKS Instruments
MKS Instruments, Inc. is a global provider of instruments, subsystems and process control solutions that measure, control, power, monitor, and analyze critical parameters of advanced manufacturing processes to improve process performance and productivity. The Companys products are derived from core competencies in pressure measurement and control, flow measurement and control, gas and vapor delivery, gas composition analysis, residual gas analysis, leak detection, control technology, ozone generation and delivery, RF & DC power, reactive gas generation, vacuum technology, lasers, photonics, sub-micron positioning, vibration isolation, and optics. MKS primary markets include semiconductor capital equipment, general industrial, life sciences, and research. Additional information can be found at www.mksinst.com.
Use of Non-GAAP Financial Results
Non-GAAP amounts exclude amortization of acquired intangible assets, asset impairments, costs associated with completed and announced acquisitions, acquisition integration costs, restructuring charges, certain excess and obsolete inventory charges, fees and expenses related to re-pricing of the Companys term loan, amortization of debt issuance costs, net proceeds from an insurance policy, costs associated with the sale of a business, the tax effects of the 2017 Tax Cut and Jobs Act, the tax effect of legal entity restructurings, other discrete tax benefits and charges, and the related tax effect of these adjustments. These non-GAAP measures are not in accordance with generally accepted accounting principles in the United States of America (GAAP). MKS management believes the presentation of these non-GAAP financial measures is useful to investors for comparing prior periods and analyzing ongoing business trends and operating results. Annualized GAAP interest expense based upon $780 million principal outstanding and using the LIBOR based interest rate spread in effect on April 29, 2016, was $44 million and included $5 million in debt issuance cost. Annualized GAAP interest expense based upon $398 million in principal currently outstanding and LIBOR plus 200 basis points would be $17.5 million and includes $4 million of debt issuance cost.
SAFE HARBOR FOR FORWARD-LOOKING STATEMENTS
This release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 regarding the future financial performance, business prospects and growth of MKS as well as expected synergies and cost savings from the acquisition of Newport Corporation. These statements are only predictions based on current assumptions and expectations. Actual events or results may differ materially from those in the forward-looking statements set forth herein. Among the important factors that could cause actual events to differ materially from those in the forward-looking statements are the conditions affecting the markets in which MKS operates, including the fluctuations in capital spending in the semiconductor industry and other advanced manufacturing markets, fluctuations in net sales to major customers, the Companys ability to successfully integrate Newports operations and employees, unexpected risks, costs, charges or expenses resulting from the Newport acquisition or other acquisitions, the terms of the term loan financing, fluctuations in interest rates, the impact of the 2017 Tax Cut and Jobs Act as additional clarification and implementation guidance is issued with respect thereto, the Companys ability to successfully grow the business, potential fluctuations in quarterly results, dependence on new product development, rapid technological and market change, acquisition strategy, manufacturing and sourcing risks, volatility of stock price, international operations, financial risk management, and the other factors described in MKS most recent Annual Report on Form 10-K for the year ended December 31, 2016 filed with SEC. MKS is under no obligation to, and expressly disclaims any obligation to, update or alter these forward-looking statements, whether as a result of new information, future events or otherwise after the date of this press release.
###
Company Contact: Seth H. Bagshaw
Senior Vice President, Chief Financial Officer and Treasurer
Telephone: 978.645.5578
Investor Relations Contacts:
Monica Gould
The Blueshirt Group
Telephone: 212.871.3927
Email: monica@blueshirtgroup.com
Lindsay Grant Savarese
The Blueshirt Group
Telephone: 212.331.8417
Email: lindsay@blueshirtgroup.com
MKS Instruments, Inc.
Unaudited Consolidated Statements of Operations
(In thousands, except per share data)
Three Months Ended | ||||||||||||
December 31, 2017 | December 31, 2016 | September 30, 2017 | ||||||||||
Net revenues: |
||||||||||||
Products |
$ | 463,851 | $ | 359,765 | $ | 434,710 | ||||||
Services |
47,949 | 45,375 | 51,557 | |||||||||
Total net revenues |
511,800 | 405,140 | 486,267 | |||||||||
Cost of revenues: |
||||||||||||
Products |
242,008 | 194,716 | 225,174 | |||||||||
Services |
31,466 | 27,016 | 33,098 | |||||||||
Total cost of revenues |
273,474 | 221,732 | 258,272 | |||||||||
Gross profit |
238,326 | 183,408 | 227,995 | |||||||||
Research and development |
33,045 | 32,870 | 32,548 | |||||||||
Selling, general and administrative |
72,510 | 67,626 | 71,839 | |||||||||
Acquisition and integration costs |
634 | 2,089 | 2,466 | |||||||||
Restructuring |
1,324 | 618 | 10 | |||||||||
Asset impairment |
| 5,000 | | |||||||||
Amortization of intangible assets |
10,797 | 12,691 | 10,977 | |||||||||
Income from operations |
120,016 | 62,514 | 110,155 | |||||||||
Interest income |
1,125 | 702 | 873 | |||||||||
Interest expense |
7,989 | 10,085 | 7,172 | |||||||||
Other expense, net |
2,155 | 3,575 | 2,485 | |||||||||
Income from operations before income taxes |
110,997 | 49,556 | 101,371 | |||||||||
Provision for income taxes |
33,359 | 4,069 | 25,377 | |||||||||
Net income |
$ | 77,638 | $ | 45,487 | $ | 75,994 | ||||||
Net income per share: |
||||||||||||
Basic |
$ | 1.43 | $ | 0.85 | $ | 1.40 | ||||||
Diluted |
$ | 1.41 | $ | 0.83 | $ | 1.38 | ||||||
Cash dividends per common share |
$ | 0.18 | $ | 0.17 | $ | 0.175 | ||||||
Weighted average shares outstanding: |
||||||||||||
Basic |
54,318 | 53,617 | 54,282 | |||||||||
Diluted |
55,236 | 54,518 | 55,101 | |||||||||
The following supplemental Non-GAAP earnings information is
presented to aid in understanding MKS operating results: |
||||||||||||
Net income |
$ | 77,638 | $ | 45,487 | $ | 75,994 | ||||||
Adjustments: |
||||||||||||
Acquisition and integration costs (Note 1) |
634 | 2,089 | 2,466 | |||||||||
Fees and expenses relating to re-pricing of term loan (Note 2) |
| 526 | 492 | |||||||||
Amortization of debt issuance costs (Note 3) |
3,983 | 2,430 | 2,314 | |||||||||
Restructuring (Note 4) |
1,324 | 618 | 10 | |||||||||
Asset impairment (Note 5) |
| 5,000 | | |||||||||
Amortization of intangible assets |
10,797 | 12,691 | 10,977 | |||||||||
Windfall tax benefit on stock-based compensation (Note 6) |
(658 | ) | | (594 | ) | |||||||
Withholding tax on dividends (Note 7) |
| 1,362 | | |||||||||
Tax benefit from a legal entity restructuring (Note 8) |
| (6,570 | ) | | ||||||||
Deferred tax adjustment (Note 9) |
(24,546 | ) | | | ||||||||
Transition tax on accumulated foreign earnings (Note 10) |
28,658 | | | |||||||||
Tax adjustment related to the sale of a business (Note 11) |
(12,131 | ) | | | ||||||||
Accrued tax on MKS subsidiary distribution (Note 12) |
14,000 | | | |||||||||
Pro-forma tax adjustments |
(5,083 | ) | (6,437 | ) | (5,789 | ) | ||||||
Non-GAAP net earnings |
$ | 94,616 | $ | 57,196 | $ | 85,870 | ||||||
Non-GAAP net earnings per share |
$ | 1.71 | $ | 1.05 | $ | 1.56 | ||||||
Weighted average shares outstanding |
55,236 | 54,518 | 55,101 | |||||||||
Income from operations |
$ | 120,016 | $ | 62,514 | $ | 110,155 | ||||||
Adjustments: |
||||||||||||
Acquisition and integration costs (Note 1) |
634 | 2,089 | 2,466 | |||||||||
Fees and expenses relating to re-pricing of term loan (Note 2) |
| 526 | 492 | |||||||||
Restructuring (Note 4) |
1,324 | 618 | 10 | |||||||||
Asset impairment (Note 5) |
| 5,000 | | |||||||||
Amortization of intangible assets |
10,797 | 12,691 | 10,977 | |||||||||
Non-GAAP income from operations |
$ | 132,771 | $ | 83,438 | $ | 124,100 | ||||||
Non-GAAP operating margin percentage |
25.9 | % | 20.6 | % | 25.5 | % | ||||||
Interest expense |
$ | 7,989 | $ | 10,085 | $ | 7,172 | ||||||
Amortization of debt issuance costs (Note 3) |
3,983 | 2,430 | 2,314 | |||||||||
Non-GAAP interest expense |
$ | 4,006 | $ | 7,655 | $ | 4,858 | ||||||
Net income |
$ | 77,638 | $ | 45,487 | $ | 75,994 | ||||||
Interest expense, net |
6,864 | 9,383 | 6,299 | |||||||||
Provision for income taxes |
33,359 | 4,069 | 25,377 | |||||||||
Depreciation |
9,208 | 9,478 | 9,153 | |||||||||
Amortization |
10,797 | 12,691 | 10,977 | |||||||||
EBITDA |
$ | 137,866 | $ | 81,108 | $ | 127,800 | ||||||
Stock-based compensation |
4,544 | 5,402 | 4,846 | |||||||||
Acquisition and integration costs (Note 1) |
634 | 2,089 | 2,466 | |||||||||
Fees and expenses relating to re-pricing of term loan (Note 2) |
| 526 | 492 | |||||||||
Restructuring (Note 4) |
1,324 | 618 | 10 | |||||||||
Asset impairment (Note 5) |
| 5,000 | | |||||||||
Other adjustments |
839 | 817 | 836 | |||||||||
Adjusted EBITDA |
$ | 145,207 | $ | 95,560 | $ | 136,450 | ||||||
Note 1: We recorded acquisition and integration costs related to the Newport Corporation acquisition, which closed during the second quarter of 2016.
Note 2: We recorded fees and expenses related to the re-pricing of our Term Loan Credit Agreement during the three month periods ended September 30, 2017 and December 31, 2016.
Note 3: We recorded additional interest expense related to the amortization of debt issuance costs affiliated with our Term Loan Credit Agreement and ABL Facility.
Note 4: We recorded restructuring costs, primarily related to the consolidation of two manufacturing plants during the three months ended December 31, 2017. We recorded restructuring costs related to one of our international facilities during the three months ended December 31, 2016.
Note 5: We recorded an asset impairment charge related to a minority interest investment in a privately held company during the three months ended December 31, 2016.
Note 6: We recorded windfall tax benefits on the vesting of stock-based compensation during the three months ended December 31, 2017 and September 30, 2017, respectively, relating to the implementation of a new accounting standard issued by the Financial Statement Accounting Standards Board (Accounting Standards Update 2016-09).
Note 7: We recorded withholding tax on intercompany dividends during the three months ended December 31, 2016.
Note 8: We recorded a tax benefit related to a legal entity restructuring during the three months ended December 31, 2016.
Note 9: We recorded a deferred tax adjustment, which also includes the reversal of a tax accrual on a French dividend, related to U.S. tax reform legislation during the three months ended December 31, 2017.
Note 10*: We recorded a transition tax on accumulated foreign earnings related to the 2017 Tax Cut and Jobs Act during the three months ended December 31, 2017.
Note 11*: We recorded a tax adjustment resulting from the 2017 Tax Cut and Jobs Act, related to the sale of our Data Analytics Solutions business during the three months ended December 31, 2017.
Note 12*: We recorded an accrual for tax expense on a potential distribution to a subsidiary, related to the 2017 Tax Cut and Jobs Act during the three months ended December 31, 2017.
*The computation of the one-time tax on our offshore earnings pursuant to the 2017 Tax Cut and Jobs Act (the Tax Act) as well as our net deferred tax liability is based on our current understanding and assumptions regarding the impact of the Tax Act, and may change as additional clarification and implementation guidance is issued and as the interpretation of the Tax Act evolves over time.
MKS Instruments, Inc.
Unaudited Consolidated Statements of Operations
(In thousands, except per share data)
Twelve Months Ended December 31, | ||||||||
2017 | 2016 | |||||||
Net revenues: |
||||||||
Products |
$ | 1,723,433 | $ | 1,134,013 | ||||
Services |
192,544 | 161,329 | ||||||
Total net revenues |
1,915,977 | 1,295,342 | ||||||
Cost of revenues: |
||||||||
Products |
901,546 | 627,850 | ||||||
Services |
122,980 | 101,873 | ||||||
Total cost of revenues |
1,024,526 | 729,723 | ||||||
Gross profit |
891,451 | 565,619 | ||||||
Research and development |
132,555 | 110,579 | ||||||
Selling, general and administrative |
290,548 | 229,171 | ||||||
Acquisition and integration costs |
5,332 | 27,279 | ||||||
Restructuring |
3,920 | 642 | ||||||
Asset impairment |
6,719 | 5,000 | ||||||
Amortization of intangible assets |
45,743 | 35,681 | ||||||
Income from operations |
406,634 | 157,267 | ||||||
Interest income |
3,021 | 2,560 | ||||||
Interest expense |
30,990 | 30,611 | ||||||
Gain on sale of business |
74,856 | | ||||||
Other expense, net |
5,896 | 1,239 | ||||||
Income from continuing operations before income taxes |
447,625 | 127,977 | ||||||
Provision for income taxes |
108,493 | 23,168 | ||||||
Net income |
$ | 339,132 | $ | 104,809 | ||||
Net income per share: |
||||||||
Basic |
$ | 6.26 | $ | 1.96 | ||||
Diluted |
$ | 6.16 | $ | 1.94 | ||||
Cash dividends per common share |
$ | 0.71 | $ | 0.68 | ||||
Weighted average shares outstanding: |
||||||||
Basic |
54,137 | 53,472 | ||||||
Diluted |
55,074 | 54,051 | ||||||
The following supplemental Non-GAAP earnings information is
presented to aid in understanding MKS operating results: |
||||||||
Net income |
$ | 339,132 | $ | 104,809 | ||||
Adjustments: |
||||||||
Acquisition and integration costs (Note 1) |
5,332 | 27,279 | ||||||
Acquisition inventory step-up (Note 2) |
| 15,090 | ||||||
Expenses related to sale of a business (Note 3) |
859 | | ||||||
Excess and obsolete inventory charge (Note 4) |
1,160 | | ||||||
Fees and expenses relating to re-pricing of term loan (Note 5) |
492 | 1,239 | ||||||
Amortization of debt issuance costs (Note 6) |
9,405 | 6,897 | ||||||
Restructuring (Note 7) |
3,920 | 642 | ||||||
Asset impairment (Note 8) |
6,719 | 5,000 | ||||||
Gain on sale of business (Note 9) |
(74,856 | ) | | |||||
Net proceeds from an insurance policy (Note 10) |
| (1,323 | ) | |||||
Amortization of intangible assets |
45,743 | 35,681 | ||||||
Taxes related to the sale of a business (Note 11) |
2,876 | | ||||||
Windfall tax benefit on stock-based compensation (Note 12) |
(11,071 | ) | | |||||
Withholding tax on dividends (Note 13) |
| 1,362 | ||||||
Tax benefit from a legal entity restructuring (Note 14) |
| (5,038 | ) | |||||
Deferred tax adjustment (Note 15) |
(24,546 | ) | | |||||
Transition tax on accumulated foreign earnings (Note 16) |
28,658 | | ||||||
Accrued tax on MKS subsidiary distribution (Note 17) |
14,000 | | ||||||
Pro-forma tax adjustments |
(19,639 | ) | (27,617 | ) | ||||
Non-GAAP net earnings |
$ | 328,184 | $ | 164,021 | ||||
Non-GAAP net earnings per share |
$ | 5.96 | $ | 3.03 | ||||
Weighted average shares outstanding |
55,074 | 54,051 | ||||||
Income from operations |
$ | 406,634 | $ | 157,267 | ||||
Adjustments: |
||||||||
Acquisition and integration costs (Note 1) |
5,332 | 27,279 | ||||||
Acquisition inventory step-up (Note 2) |
| 15,090 | ||||||
Expenses related to the sale of a business (Note 3) |
859 | | ||||||
Excess and obsolete inventory charge (Note 4) |
1,160 | | ||||||
Fees and expenses relating to re-pricing of term loan (Note 5) |
492 | 1,239 | ||||||
Restructuring (Note 7) |
3,920 | 642 | ||||||
Asset impairment (Note 8) |
6,719 | 5,000 | ||||||
Amortization of intangible assets |
45,743 | 35,681 | ||||||
Non-GAAP income from operations |
$ | 470,859 | $ | 242,198 | ||||
Non-GAAP operating margin percentage |
24.6 | % | 18.7 | % | ||||
Gross profit |
$ | 891,451 | $ | 565,619 | ||||
Acquisition inventory step-up (Note 2) |
| 15,090 | ||||||
Excess and obsolete inventory charge (Note 4) |
1,160 | | ||||||
Non-GAAP gross profit |
$ | 892,611 | $ | 580,709 | ||||
Non-GAAP gross profit percentage |
46.6 | % | 44.8 | % | ||||
Interest expense |
$ | 30,990 | $ | 30,611 | ||||
Amortization of debt issuance costs (Note 6) |
9,405 | 6,897 | ||||||
Non-GAAP interest expense |
$ | 21,585 | $ | 23,714 | ||||
Net income |
$ | 339,132 | $ | 104,809 | ||||
Interest expense, net |
27,969 | 28,051 | ||||||
Provision for income taxes |
108,493 | 23,168 | ||||||
Depreciation |
36,813 | 30,245 | ||||||
Amortization |
45,743 | 35,681 | ||||||
EBITDA |
$ | 558,150 | $ | 221,954 | ||||
Stock-based compensation |
24,378 | 25,228 | ||||||
Acquisition and integration costs (Note 1) |
5,332 | 27,279 | ||||||
Acquisition inventory step-up (Note 2) |
| 15,090 | ||||||
Expenses related to the sale of a business (Note 3) |
859 | | ||||||
Excess and obsolete inventory charge (Note 4) |
1,160 | | ||||||
Fees and expenses relating to re-pricing of term loan (Note 5) |
492 | 1,239 | ||||||
Restructuring (Note 7) |
3,920 | 642 | ||||||
Asset impairment (Note 8) |
6,719 | 5,000 | ||||||
Gain on sale of business (Note 9) |
(74,856 | ) | | |||||
Net proceeds from an insurance policy (Note 10) |
| (1,323 | ) | |||||
Other adjustments |
3,244 | 2,312 | ||||||
Adjusted EBITDA |
$ | 529,398 | $ | 297,421 | ||||
Note 1: We recorded acquisition and integration costs related to the Newport Corporation acquisition, which closed during the second quarter of 2016.
Note 2: We recorded a charge in cost of sales related to the step-up of inventory to fair value as a result of the Newport Corporation acquisition during the twelve months ended December 31, 2016.
Note 3: We recorded legal, consulting and compensation related expenses related to the sale of a business, which was completed in April of 2017, during the twelve months ended December 31, 2017.
Note 4: We recorded excess and obsolete inventory charges in cost of sales related to the discontinuation of a product line in connection with the consolidation of two manufacturing plants during the twelve months ended December 31, 2017.
Note 5: We recorded fees and expenses related to re-pricings of our Term Loan Credit Agreement.
Note 6: We recorded additional interest expense related to the amortization of debt issuance costs affiliated with our Term Loan Credit Agreement and ABL Facility.
Note 7: We recorded restructuring costs related to the consolidation of two manufacturing plants, a restructuring of one of our international facilities and the consolidation of sales offices during the twelve months ended December 31, 2017. We recorded restructuring costs related to one of our international facilities during the twelve months ended December 31, 2016.
Note 8: We recorded an asset impairment charge, primarily related to the write-off of goodwill and intangible assets, in conjunction with the consolidation of two manufacturing plants during the twelve months ended December 31, 2017. We recorded an impairment charge related to a minority interest investment in a privately held company during the twelve months ended December 31, 2016.
Note 9: We recorded a gain on the sale of our Data Analytics Solutions business during the twelve months ended December 31, 2017.
Note 10: We recorded net proceeds from a Company owned life insurance policy during the twelve months ended December 31, 2016.
Note 11: We recorded taxes related to the sale of our Data Analytics Solutions business during the twelve months ended December 31, 2017.
Note 12: We recorded a windfall tax benefit on the vesting of stock-based compensation relating to the implementation of a new accounting standard issued by the Financial Statement Accounting Standards Board (Accounting Standards Update 2016-09) during the twelve months ended December 31, 2017.
Note 13: We recorded a withholding tax on intercompany dividends during the twelve months ended December 31, 2016.
Note 14: We recorded a tax benefit related to a legal entity restructuring during the twelve months ended December 31, 2016.
Note 15*: We recorded a deferred tax adjustment, which also includes the reversal of a tax accrual on a French dividend, related to the 2017 Tax Cut and Jobs Act during the twelve months ended December 31, 2017.
Note 16*: We recorded a transition tax on accumulated foreign earnings related to the 2017 Tax Cut and Jobs Act during the twelve months ended December 31, 2017.
Note 17*: We recorded an accrual for tax expense on a potential distribution to a subsidiary, related to the 2017 Tax Cut and Jobs Act during the twelve months ended December 31, 2017.
*The computation of the one-time tax on our offshore earnings pursuant to the 2017 Tax Cut and Jobs Act (the Tax Act) as well as our net deferred tax liability is based on our current understanding and assumptions regarding the impact of the Tax Act, and may change as additional clarification and implementation guidance is issued and as the interpretation of the Tax Act evolves over time.
MKS Instruments, Inc.
Unaudited Consolidated Statements of Cash Flows
(In thousands, except per share data)
Three Months Ended | ||||||||||||
December 31, 2017 | December 31, 2016 | September 30, 2017 | ||||||||||
Cash flows from operating activities: |
||||||||||||
Net income |
$ | 77,638 | $ | 45,487 | $ | 75,994 | ||||||
Adjustments to reconcile net income to net cash provided by
operating activities: |
||||||||||||
Depreciation and amortization |
20,006 | 22,169 | 20,130 | |||||||||
Amortization of debt issuance costs and original issue discount |
4,314 | 2,812 | 2,643 | |||||||||
Stock-based compensation |
4,544 | 5,402 | 4,845 | |||||||||
Provision for excess and obsolete inventory |
4,864 | 4,994 | 4,347 | |||||||||
Provision for doubtful accounts |
175 | 943 | 139 | |||||||||
Deferred income taxes |
(16,528 | ) | (29,255 | ) | (1,157 | ) | ||||||
Excess tax benefit from stock-based compensation |
| (790 | ) | | ||||||||
Asset impairment |
| 5,000 | | |||||||||
Other |
(7 | ) | 131 | 36 | ||||||||
Changes in operating assets and liabilities |
(14,220 | ) | (4,172 | ) | (8,014 | ) | ||||||
Net cash provided by operating activities |
80,786 | 52,721 | 98,963 | |||||||||
Cash flows from investing activities: |
||||||||||||
Purchases of investments |
(30,545 | ) | (152,383 | ) | (129,430 | ) | ||||||
Sales of investments |
9,993 | 1,404 | 18,252 | |||||||||
Maturities of investments |
40,563 | 12,311 | 31,545 | |||||||||
Purchases of property, plant and equipment |
(13,431 | ) | (7,164 | ) | (8,118 | ) | ||||||
Other |
66 | 232 | | |||||||||
Net cash provided by (used in) investing activities |
6,646 | (145,600 | ) | (87,751 | ) | |||||||
Cash flows from financing activities: |
||||||||||||
Restricted cash |
(177 | ) | 316 | 5,163 | ||||||||
Payments of short-term borrowings |
(16,435 | ) | (3,453 | ) | (4,020 | ) | ||||||
Proceeds from short and long-term borrowings |
15,394 | 4,438 | 4,522 | |||||||||
Payments of long-term borrowings |
(50,000 | ) | (41,570 | ) | (125,000 | ) | ||||||
Dividend payments |
(9,775 | ) | (9,112 | ) | (9,500 | ) | ||||||
Excess tax benefit from stock-based compensation |
| 790 | | |||||||||
Net proceeds related to employee stock awards |
2,504 | 1,186 | (1,306 | ) | ||||||||
Net cash used in financing activities |
(58,489 | ) | (47,405 | ) | (103,141 | ) | ||||||
Effect of exchange rate changes on cash and cash equivalents |
(1,152 | ) | 2,033 | 2,076 | ||||||||
Increase (decrease) in cash and cash equivalents |
27,791 | (138,251 | ) | (116,853 | ) | |||||||
Cash and cash equivalents at beginning of period |
305,977 | 366,874 | 422,830 | |||||||||
Cash and cash equivalents at end of period |
$ | 333,768 | $ | 228,623 | $ | 305,977 | ||||||
MKS Instruments, Inc.
Unaudited Consolidated Statements of Cash Flows
(In thousands, except per share data)
Twelve Months Ended | ||||||||
December 31, 2017 | December 31, 2016 | |||||||
Cash flows from operating activities: |
||||||||
Net income |
$ | 339,132 | $ | 104,809 | ||||
Adjustments to reconcile net income to net cash provided by operating activities: |
||||||||
Depreciation and amortization |
82,556 | 65,926 | ||||||
Amortization of inventory step-up adjustment to fair value |
| 15,090 | ||||||
Amortization of debt issuance costs and original issue discount |
10,699 | 9,265 | ||||||
Stock-based compensation |
24,378 | 25,228 | ||||||
Provision for excess and obsolete inventory |
20,213 | 16,039 | ||||||
Provision for doubtful accounts |
825 | 1,109 | ||||||
Deferred income taxes |
(9,886 | ) | (38,822 | ) | ||||
Excess tax benefit from stock-based compensation |
| (1,468 | ) | |||||
Asset impairment |
6,719 | 5,000 | ||||||
Gain on sale of business |
(74,856 | ) | | |||||
Other |
824 | 256 | ||||||
Changes in operating assets and liabilities |
(45,382 | ) | (22,334 | ) | ||||
Net cash provided by operating activities |
355,222 | 180,098 | ||||||
Cash flows from investing activities: |
||||||||
Net proceeds from the sale of business |
72,509 | | ||||||
Acquisition of businesses, net of cash acquired |
| (939,591 | ) | |||||
Purchases of investments |
(229,557 | ) | (268,458 | ) | ||||
Sales of investments |
53,564 | 338,996 | ||||||
Maturities of investments |
157,342 | 160,917 | ||||||
Purchases of property, plant and equipment |
(31,287 | ) | (19,123 | ) | ||||
Other |
66 | 273 | ||||||
Net cash provided by (used in) investing activities |
22,637 | (726,986 | ) | |||||
Cash flows from financing activities: |
||||||||
Restricted cash |
4,835 | (5,860 | ) | |||||
Payments of short-term borrowings |
(29,711 | ) | (11,742 | ) | ||||
Proceeds from short-term borrowings |
28,360 | 18,964 | ||||||
Payments of long-term borrowings |
(228,141 | ) | (153,395 | ) | ||||
Proceeds from long-term borrowings |
191 | 744,653 | ||||||
Repurchases of common stock |
| (1,545 | ) | |||||
Dividend payments |
(38,178 | ) | (36,361 | ) | ||||
Excess tax benefit from stock-based compensation |
| 1,468 | ||||||
Net proceeds related to employee stock awards |
(12,215 | ) | (1,922 | ) | ||||
Net cash (used in) provided by financing activities |
(274,859 | ) | 554,260 | |||||
Effect of exchange rate changes on cash and cash equivalents |
2,145 | (6,323 | ) | |||||
Increase in cash and cash equivalents |
105,145 | 1,049 | ||||||
Cash and cash equivalents at beginning of year |
228,623 | 227,574 | ||||||
Cash and cash equivalents at end of year |
$ | 333,768 | $ | 228,623 | ||||
MKS Instruments, Inc.
Reconciliation of GAAP Income Tax Rate to Non-GAAP Income Tax Rate
(In thousands)
Three Months Ended December 31, 2017 | Three Months Ended September 30, 2017 | |||||||||||||||||||||||
Provision (benefit) | Provision | |||||||||||||||||||||||
Income Before | for | Effective | Income Before | (benefit) for | Effective | |||||||||||||||||||
Income Taxes | Income Taxes | Tax Rate | Income Taxes | Income Taxes | Tax Rate | |||||||||||||||||||
GAAP |
$ | 110,997 | $ | 33,359 | 30.1% | $ | 101,371 | $ | 25,377 | 25.0% | ||||||||||||||
Adjustments: |
||||||||||||||||||||||||
Acquisition and integration costs |
634 | | 2,466 | | ||||||||||||||||||||
(Note 1) |
||||||||||||||||||||||||
Fees and expenses relating to |
| | 492 | | ||||||||||||||||||||
re-pricing of term loan (Note 5) |
||||||||||||||||||||||||
Amortization of debt issuance |
3,983 | | 2,314 | | ||||||||||||||||||||
costs (Note 6) |
||||||||||||||||||||||||
Restructuring (Note 7) |
1,324 | | 10 | | ||||||||||||||||||||
Amortization of intangible assets |
10,797 | | 10,977 | | ||||||||||||||||||||
Windfall tax benefit on |
| 658 | | 594 | ||||||||||||||||||||
stock-based compensation (Note 10) |
||||||||||||||||||||||||
Deferred tax adjustment (Note 15) |
| 24,546 | | | ||||||||||||||||||||
Transition tax on accumulated |
| (28,658 | ) | | | |||||||||||||||||||
foreign earnings (Note 16) |
||||||||||||||||||||||||
Accrued tax on MKS subsidiary |
| (14,000 | ) | | | |||||||||||||||||||
distribution (Note 17) |
||||||||||||||||||||||||
Tax adjustment related to the sale |
| 12,131 | | | ||||||||||||||||||||
of a business (Note 11) |
||||||||||||||||||||||||
Tax effect of pro-forma adjustments |
| 5,083 | | 5,789 | ||||||||||||||||||||
Non-GAAP |
$ | 127,735 | $ | 33,119 | 25.9% | $ | 117,630 | $ | 31,760 | 27.0% | ||||||||||||||
Three Months Ended December 31, 2016 | ||||||||||||
Provision | ||||||||||||
Income Before | (benefit) for | Effective | ||||||||||
Income Taxes | Income Taxes | Tax Rate | ||||||||||
GAAP |
$ | 49,556 | $ | 4,069 | 8.2% | |||||||
Adjustments: |
||||||||||||
Acquisition and integration costs (Note 1) |
2,089 | | ||||||||||
Fees and expenses relating to re-pricing of term loan (Note 5) |
526 | | ||||||||||
Amortization of debt issuance costs (Note 6) |
2,430 | | ||||||||||
Restructuring (Note 7) |
618 | | ||||||||||
Asset impairment (Note 8) |
5,000 | | ||||||||||
Amortization of intangible assets |
12,691 | | ||||||||||
Taxes related to a legal entity restructuring (Note 13) |
| 6,570 | ||||||||||
Withholding tax on dividends (Note 14) |
| (1,362 | ) | |||||||||
Tax effect of pro-forma adjustments |
| 6,437 | ||||||||||
Non-GAAP |
$ | 72,910 | $ | 15,714 | 21.6% | |||||||
Twelve Months Ended December 31, 2017 | Twelve Months Ended December 31, 2016 | |||||||||||||||||||||||
Provision (benefit) | Provision | |||||||||||||||||||||||
Income Before | for | Effective | Income Before | (benefit) for | Effective | |||||||||||||||||||
Income Taxes | Income Taxes | Tax Rate | Income Taxes | Income Taxes | Tax Rate | |||||||||||||||||||
GAAP |
$ | 447,625 | $ | 108,493 | 24.2% | $ | 127,977 | $ | 23,168 | 18.1% | ||||||||||||||
Adjustments: |
||||||||||||||||||||||||
Acquisition and integration costs |
5,332 | | 27,279 | | ||||||||||||||||||||
(Note 1) |
||||||||||||||||||||||||
Acquisition inventory step-up (Note 2) |
| | 15,090 | | ||||||||||||||||||||
Expenses related to the sale of a |
859 | | | | ||||||||||||||||||||
business (Note 3) |
||||||||||||||||||||||||
Excess and obsolete inventory charge |
1,160 | | | | ||||||||||||||||||||
(Note 4) |
||||||||||||||||||||||||
Fees and expenses relating to |
492 | | 1,239 | | ||||||||||||||||||||
re-pricing of term loan (Note 5) |
||||||||||||||||||||||||
Amortization of debt issuance costs |
9,405 | | 6,897 | | ||||||||||||||||||||
(Note 6) |
||||||||||||||||||||||||
Restructuring (Note 7) |
3,920 | | 642 | | ||||||||||||||||||||
Asset impairment (Note 8) |
6,719 | | 5,000 | | ||||||||||||||||||||
Gain on sale of business (Note 9) |
(74,856 | ) | | | | |||||||||||||||||||
Amortization of intangible assets |
45,743 | | 35,681 | | ||||||||||||||||||||
Windfall tax benefit on stock-based |
| 11,071 | | | ||||||||||||||||||||
compensation (Note 10) |
||||||||||||||||||||||||
Taxes related to the sale of a |
| (2,876 | ) | | | |||||||||||||||||||
business (Note 11) |
||||||||||||||||||||||||
Net proceeds from an insurance policy |
| | (1,323 | ) | | |||||||||||||||||||
(Note 12) |
||||||||||||||||||||||||
Taxes related to a legal entity |
| | | 5,038 | ||||||||||||||||||||
restructuring (Note 13) |
||||||||||||||||||||||||
Withholding tax on dividends (Note 14) |
| | | (1,362 | ) | |||||||||||||||||||
Deferred tax adjustment (Note 15) |
| 24,546 | | | ||||||||||||||||||||
Transition tax on accumulated foreign |
| (28,658 | ) | | | |||||||||||||||||||
earnings (Note 16) |
||||||||||||||||||||||||
Accrued tax on MKS subsidiary |
| (14,000 | ) | | | |||||||||||||||||||
distribution (Note 17) |
||||||||||||||||||||||||
Tax effect of pro-forma adjustments |
| 19,639 | | 27,617 | ||||||||||||||||||||
Non-GAAP |
$ | 446,399 | $ | 118,215 | 26.5% | $ | 218,482 | $ | 54,461 | 24.9% | ||||||||||||||
Note 1: Acquisition and integration costs during the three and twelve months ended December 31, 2017 and 2016 relate to the Newport Corporation acquisition, which closed during the second quarter of 2016.
Note 2: We recorded a charge in cost of sales related to the step-up of inventory to fair value as a result of the Newport Corporation acquisition, during the twelve months ended December 31, 2016.
Note 3: We recorded expenses related to the sale of a business, which was completed in April of 2017, during the twelve months ended December 31, 2017.
Note 4: We recorded excess and obsolete inventory charges in cost of sales related to the discontinuation of a product line in connection with the consolidation of two manufacturing plants, during the twelve months ended December 31, 2017.
Note 5: We recorded fees and expenses related to the re-pricing of our Term Loan Credit Agreement, during the three months ended September 30, 2017 and December 31, 2016 and the twelve months ended December 31, 2017 and 2016.
Note 6: Amortization of debt issuance costs are affiliated with our Term Loan Credit Agreement and ABL Facility.
Note 7: We recorded restructuring costs primarily related to the consolidation of two manufacturing plants and costs related to a restructuring of one of our international facilities and the consolidation of sales offices during the three and twelve months ended December 31, 2017. We recorded restructuring costs related to the restructuring of one of our international facilities during the twelve months ended December 31, 2016.
Note 8: We recorded an asset impairment charge, during the twelve months ended December 31, 2017, primarily related to the write-off of goodwill and intangible assets, in conjunction with the consolidation of two manufacturing plants. We recorded an impairment charge during the three and twelve months ended December 31, 2016, related to a minority interest investment in a privately held company.
Note 9: We recorded a gain on the sale of our Data Analytics Solutions business during the twelve months ended December 31, 2017.
Note 10: We recorded a windfall tax benefit on the vesting of stock-based compensation, relating to the implementation of a new accounting standard issued by the Financial Statement Accounting Standards Board (Accounting Standards Update 2016-09).
Note 11: We recorded taxes related to the sale of our Data Analytics Solutions business during the twelve months ended December 31, 2017. The three months ended December 31, 2017 includes a tax adjustment related to the sale of our Data Analytics Solutions business resulting from U.S. tax reform legislation.
Note 12: We recorded net proceeds from a Company owned life insurance policy during the twelve months ended December 31, 2016.
Note 13: We recorded a tax expense related to a legal entity restructuring during the twelve months ended December 31, 2016.
Note 14: We recorded withholding tax on intercompany dividends during the three and twelve months ended December 31, 2016.
Note 15*: We recorded a deferred tax adjustment, which also includes the reversal of a tax accrual on a French dividend, related to the 2017 Tax Cut and Jobs Act during the three and twelve months ended December 31, 2017.
Note 16*: We recorded a transition tax on accumulated foreign earnings related to the 2017 Tax Cut and Jobs Act during the three and twelve months ended December 31, 2017.
Note 17*: We recorded an accrual for tax expense on a potential distribution to a subsidiary, related to the 2017 Tax Cut and Jobs Act during the three and twelve months ended December 31, 2017.
*The computation of the one-time tax on our offshore earnings pursuant to the 2017 Tax Cut and Jobs Act (the Tax Act) as well as our net deferred tax liability is based on our current understanding and assumptions regarding the impact of the Tax Act, and may change as additional clarification and implementation guidance is issued and as the interpretation of the Tax Act evolves over time.
MKS Instruments, Inc.
Reconciliation of Q1-18 Guidance GAAP Net Income to Non-GAAP Net Earnings
(In thousands, except per share data)
Three Months Ended March 31, 2018 | ||||||||||||||||
Low Guidance | High Guidance | |||||||||||||||
$ Amount | $ Per Share | $ Amount | $ Per Share | |||||||||||||
GAAP net income |
$ | 93,200 | $ | 1.68 | $ | 108,100 | $ | 1.95 | ||||||||
Amortization |
11,000 | 0.20 | 11,000 | 0.20 | ||||||||||||
Deferred financing costs |
900 | 0.02 | 900 | 0.02 | ||||||||||||
Tax effect of adjustments (Note 1) |
(2,200 | ) | (0.04 | ) | (2,300 | ) | (0.04 | ) | ||||||||
Non-GAAP net earnings |
$ | 102,900 | $ | 1.86 | $ | 117,700 | $ | 2.12 | ||||||||
Q1 18 forecasted shares |
55,400 | 55,400 |
Note 1: The Non-GAAP adjustments are tax effected at the applicable statutory rates and the difference between the GAAP and Non-GAAP tax rates.
MKS Instruments, Inc.
Unaudited Consolidated Balance Sheet
(In thousands)
December 31, 2017 | December 31, 2016 | |||||||
ASSETS |
||||||||
Cash and cash equivalents |
$ | 333,768 | $ | 228,623 | ||||
Restricted cash |
119 | 5,287 | ||||||
Short-term investments |
209,434 | 189,463 | ||||||
Trade accounts receivable, net |
300,308 | 248,757 | ||||||
Inventories |
339,081 | 275,869 | ||||||
Other current assets |
53,543 | 50,770 | ||||||
Total current assets |
1,236,253 | 998,769 | ||||||
Property, plant and equipment, net |
171,782 | 174,559 | ||||||
Goodwill |
591,047 | 588,585 | ||||||
Intangible assets, net |
366,398 | 408,004 | ||||||
Long-term investments |
10,655 | 9,858 | ||||||
Other assets |
37,883 | 32,467 | ||||||
Total assets |
$ | 2,414,018 | $ | 2,212,242 | ||||
LIABILITIES AND STOCKHOLDERS EQUITY |
||||||||
Short-term debt |
$ | 2,972 | $ | 10,993 | ||||
Accounts payable |
82,518 | 69,337 | ||||||
Accrued compensation |
96,147 | 67,728 | ||||||
Income taxes payable |
25,106 | 22,794 | ||||||
Deferred revenue |
12,842 | 14,463 | ||||||
Other current liabilities |
73,945 | 51,985 | ||||||
Total current liabilities |
293,530 | 237,300 | ||||||
Long-term debt, net |
389,993 | 601,229 | ||||||
Non-current deferred taxes |
56,516 | 66,446 | ||||||
Non-current accrued compensation |
51,700 | 44,714 | ||||||
Other liabilities |
33,372 | 20,761 | ||||||
Total liabilities |
825,111 | 970,450 | ||||||
Stockholders equity: |
||||||||
Common stock |
113 | 113 | ||||||
Additional paid-in capital |
789,644 | 777,482 | ||||||
Retained earnings |
795,698 | 494,744 | ||||||
Accumulated other comprehensive loss |
3,452 | (30,547 | ) | |||||
Total stockholders equity |
1,588,907 | 1,241,792 | ||||||
Total liabilities and stockholders equity |
$ | 2,414,018 | $ | 2,212,242 | ||||